181 related articles for article (PubMed ID: 10938272)
1. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.
Zhou Q; Melkoumian ZK; Lucktong A; Moniwa M; Davie JR; Strobl JS
J Biol Chem; 2000 Nov; 275(45):35256-63. PubMed ID: 10938272
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects.
Sambucetti LC; Fischer DD; Zabludoff S; Kwon PO; Chamberlin H; Trogani N; Xu H; Cohen D
J Biol Chem; 1999 Dec; 274(49):34940-7. PubMed ID: 10574969
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.
Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM
Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645
[TBL] [Abstract][Full Text] [Related]
5. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins.
Strait KA; Dabbas B; Hammond EH; Warnick CT; Iistrup SJ; Ford CD
Mol Cancer Ther; 2002 Nov; 1(13):1181-90. PubMed ID: 12479699
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition.
Rideout HJ; Wang Q; Park DS; Stefanis L
J Neurosci; 2003 Feb; 23(4):1237-45. PubMed ID: 12598612
[TBL] [Abstract][Full Text] [Related]
8. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.
Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Hyun YL; Choi J
Breast Cancer Res Treat; 2011 Nov; 130(2):365-75. PubMed ID: 21184271
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.
Thakur VS; Gupta K; Gupta S
Carcinogenesis; 2012 Feb; 33(2):377-84. PubMed ID: 22114073
[TBL] [Abstract][Full Text] [Related]
10. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.
Bai J; Nakamura H; Ueda S; Kwon YW; Tanaka T; Ban S; Yodoi J
J Biol Chem; 2004 Sep; 279(37):38710-4. PubMed ID: 15247282
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
Richon VM; Sandhoff TW; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
Wagenknecht B; Hermisson M; Eitel K; Weller M
Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B.
Fuino L; Bali P; Wittmann S; Donapaty S; Guo F; Yamaguchi H; Wang HG; Atadja P; Bhalla K
Mol Cancer Ther; 2003 Oct; 2(10):971-84. PubMed ID: 14578462
[TBL] [Abstract][Full Text] [Related]
14. Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced.
Kamitani H; Taniura S; Watanabe K; Sakamoto M; Watanabe T; Eling T
Neuro Oncol; 2002 Apr; 4(2):95-101. PubMed ID: 11916500
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase.
Butler LM; Webb Y; Agus DB; Higgins B; Tolentino TR; Kutko MC; LaQuaglia MP; Drobnjak M; Cordon-Cardo C; Scher HI; Breslow R; Richon VM; Rifkind RA; Marks PA
Clin Cancer Res; 2001 Apr; 7(4):962-70. PubMed ID: 11309347
[TBL] [Abstract][Full Text] [Related]
17. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors.
Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK
Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.
Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB
Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842
[TBL] [Abstract][Full Text] [Related]
19. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
Chen YX; Fang JY; Lu J; Qiu DK
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
